Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotypic variability in familial hypercholesterolaemia: an update.

Angelique C M Jansen1, Sanne van Wissen, Joep C Defesche

  • 1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Current Opinion in Lipidology
|March 14, 2002
PubMed
Summary

Familial hypercholesterolemia, a common inherited disorder, causes high LDL-cholesterol and early heart disease. This review explores factors influencing disease severity beyond the main genetic defect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coefficient of variation-defined glycemic variability is associated with ICU mortality in critically ill influenza patients.

BMC infectious diseases·2026
Same author

Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial.

The lancet. Diabetes & endocrinology·2026
Same author

Clinical Characteristics and Outcomes of ICU Patients During the First Post-COVID-19 2023-2024 Influenza Season in The Netherlands.

Viruses·2025
Same author

Counseling couples at risk of having a child with homozygous familial hypercholesterolemia - Clinical experience and recommendations.

Journal of clinical lipidology·2023
Same author

Use of Lipoprotein(a) to improve diagnosis and management in clinical familial hypercholesterolemia.

Atherosclerosis·2022
Same author

Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.

Clinical genetics·2022

Area of Science:

  • Genetics
  • Cardiology
  • Metabolic Disorders

Background:

  • Familial hypercholesterolemia (FH) is a prevalent autosomal dominant genetic disorder.
  • It is characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels.
  • FH significantly increases the risk of premature atherosclerotic cardiovascular disease.

Purpose of the Study:

  • To review recent advancements in understanding FH.
  • To explore factors contributing to clinical variability in FH patients.
  • To discuss the interplay between genetic defects and other risk factors.

Main Methods:

  • Literature review of recent studies on FH.
  • Analysis of genetic, environmental, and metabolic factors.
  • Synthesis of current knowledge on FH phenotype modification.

Related Experiment Videos

Main Results:

  • FH is caused by monogenic defects, primarily in the LDL receptor pathway.
  • Significant phenotypic heterogeneity exists among FH patients.
  • Environmental, metabolic, and other genetic factors modulate disease onset and severity.

Conclusions:

  • Understanding FH requires considering factors beyond the primary genetic defect.
  • Further research into modifying factors can improve FH management.
  • Personalized risk assessment is crucial for FH patients.